← Eichor
Condition: Systolic Left Ventricular Dysfunction Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Systolic Left Ventricular Dysfunction

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricula
Phase 2/Phase 3 · 107 location(s) · Merck Sharp & Dohme LLC · NCT05714085
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
NA · 43 location(s) · Sunnybrook Health Sciences Centre · NCT05427370
Left Septal Pacing or Left Bundle Branch Pacing to Avoid Left Ventricle Systolic Dysfunction
NA · 1 location(s) · Parc de Salut Mar · NCT06707662
AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Targe
NA · 1 location(s) · Tri-Service General Hospital (TSGH) · NCT07355023
Ketamine-lidocaine Versus Ketamine-fentanyl for Induction of Anesthesia in Patients With Left Ventricular Systolic Dysfu
NA · 1 location(s) · Cairo University · NCT07248202
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Bo
Phase 3 · 133 location(s) · Bayer · NCT07188805
Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patient
Phase N/A · 1 location(s) · Samsung Medical Center · NCT06243653
Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study
Phase N/A · 1 location(s) · Mayo Clinic · NCT06770062
The Predictive Value of Dobutamine Echo-stress in the Clinical Response to CCM Therapy in Advanced HF
Phase N/A · 13 location(s) · Quovadis Associazione · NCT06973902
Hybrid Ablation of Atrial Fibrillation in Heart Failure
NA · 7 location(s) · St. George's Hospital, London · NCT05411614
AI ECG Algorithm for Detecting LV Systolic Dysfunction
Phase N/A · 1 location(s) · Ajou University School of Medicine · NCT07636759
Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an
Phase 2 · 1 location(s) · Ralf Rothoerl · NCT06705023
Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
Phase N/A · 1 location(s) · Herlev and Gentofte Hospital · NCT04950218
The C-MIC-II Follow-Up Study
NA · 6 location(s) · Berlin Heals GmbH · NCT05189860
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · 132 location(s) · Bayer · NCT07192952
Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure
Phase 4 · 1 location(s) · Raffaele De Caterina · NCT06270498
Pediatric Cardiomyopathy Mutation Analysis
Phase N/A · 1 location(s) · Indiana University · NCT02432092
Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead
NA · 4 location(s) · Berlin Heals GmbH · NCT06920030
AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)
Phase N/A · 1 location(s) · Yonsei University · NCT06811519
STICH3C Cardiac Magnetic Resonance Observational Study
Phase N/A · 9 location(s) · Weill Medical College of Cornell University · NCT07133984
ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing
Phase N/A · 31 location(s) · University Hospital of Ferrara · NCT06324682
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.